Page last updated: 2024-11-06

2,2',4,6,6'-pentachlorobiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2,2',4,6,6'-pentachlorobiphenyl, also known as PCB 153, is a highly chlorinated polychlorinated biphenyl (PCB) congener. It is a persistent organic pollutant (POP) and a known environmental contaminant. PCB 153 is often used as a marker for total PCB contamination in environmental samples. It is a non-flammable, colorless, viscous liquid with a melting point of 60-62 degrees Celsius. PCBs are synthesized through the reaction of chlorine with biphenyl in the presence of a catalyst, typically a Lewis acid. This congener is particularly persistent in the environment and accumulates in the food chain, especially in fatty tissues of animals. It is classified as a probable human carcinogen by the International Agency for Research on Cancer (IARC). PCB 153 has been linked to various adverse health effects in humans and animals, including endocrine disruption, immune system suppression, reproductive problems, developmental toxicity, and cancer. Its presence in the environment is a major concern, as it can bioaccumulate in organisms and pose a threat to human and ecosystem health. The persistence, bioaccumulation, and toxic effects of PCB 153 make it a primary target for environmental monitoring and remediation efforts.'

Cross-References

ID SourceID
PubMed CID91662
SCHEMBL ID4452879
MeSH IDM0375116

Synonyms (17)

Synonym
1,1'-biphenyl, 2,2',4,6,6'-pentachloro-
2,2',4,6,6'-pentachloro-1,1'-biphenyl
pcb 104
2,2',4,6,6'-pentachlorobiphenyl
2,4,6,2',6'-pentachlorobiphenyl
1,3,5-trichloro-2-(2,6-dichlorophenyl)benzene
56558-16-8
unii-z4yyf101n3
z4yyf101n3 ,
SCHEMBL4452879
MTCPZNVSDFCBBE-UHFFFAOYSA-N
DTXSID0074184 ,
1,1'-biphenyl, 2,2',4,6,6'-pentachloro-; 2,2',4,6,6'-pentachloro-1,1'-biphenyl; 2,2',4,6,6'-pentachlorobiphenyl; 2,4,6,2',6'-pentachlorobiphenyl; pcb 104; 2,2',4,6,6'-pentacb
pcb no. 104
Q27294999
CS-0453782
dtxcid4042090
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (80.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.63 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (10.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]